Folia Biologica
Journal of Cellular and Molecular Biology, Charles University 

Crossref logo

Fol. Biol. 2024, 70, 262-269

https://doi.org/10.14712/fb2024070050262

Down-regulation of lncRNA EMX2OS Is Associated with the Prognosis of Patients with Cervical Squamous Cell Carcinoma and Regulates Tumour Cell Progression via miR-574-5p

Quan Cheng1, Ting Hu2, Wenhui Zhang3, Wei Shang4, Jinwei Cao5, Huijuan Zhao6, Haiyan Wang2

1Department of Traditional Chinese Medicine, Affiliated Hangzhou First People’s Hospital, School of Medicine, Westlake University, Hangzhou, China
2Department of Gynecology and Obstetrics, Huian County Hospital, Quanzhou, China
3Department of Medical Imaging, The Third Hospital of Shijiazhuang, Shijiazhuang, Hebei, China
4Department of Obstetrics and Gynecology, Renqiu People’s Hospital, Renqiu, Hebei, China
5Department of Medical Imaging, The Sixth Hospital of Shijiazhuang, Shijiazhuang, Hebei, China
6Second Department of Obstetrics and Gynecology, The Sixth Hospital of Shijiazhuang, Shijiazhuang, Hebei, China

Received June 2024
Accepted November 2024

References

1. Buskwofie, A., David-West, G., Clare, C. A. (2020) A review of cervical cancer: incidence and disparities. J. Natl. Med. Assoc. 112, 229-232.
2. Chargari, C., Peignaux, K., Escande, A. et al. (2022) Radiotherapy of cervical cancer. Cancer Radiother. 26, 298-308. <https://doi.org/10.1016/j.canrad.2021.11.009>
3. Chen, B., Dragomir, M. P., Yang, C. et al. (2022) Targeting non-coding RNAs to overcome cancer therapy resistance. Signal Transduct. Target. Ther. 7, 121. <https://doi.org/10.1038/s41392-022-00975-3>
4. Chen, P., Zhang, W., Chen, Y. et al. (2020) Comprehensive analysis of aberrantly expressed long non‑coding RNAs, microRNAs, and mRNAs associated with the competitive endogenous RNA network in cervical cancer. Mol. Med. Rep. 22, 405-415. <https://doi.org/10.3892/mmr.2020.11120>
5. Duan, M., Fang, M., Wang, C. et al. (2020) LncRNA EMX2OS induces proliferation, invasion and sphere formation of ovarian cancer cells via regulating the miR-654-3p/AKT3/PD-L1 axis. Cancer Manag. Res. 12, 2141-2154. <https://doi.org/10.2147/CMAR.S229013>
6. Gu, Y., Feng, C., Liu, T. et al. (2018) The downregulation of lncRNA EMX2OS might independently predict shorter recurrence-free survival of classical papillary thyroid cancer. PLoS One 13, e0209338. <https://doi.org/10.1371/journal.pone.0209338>
7. Huang, D. W., Sherman, B. T., Lempicki, R. A. (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57. <https://doi.org/10.1038/nprot.2008.211>
8. Jiang, H., Chen, H., Wan, P. et al. (2020) Downregulation of enhancer RNA EMX2OS is associated with poor prognosis in kidney renal clear cell carcinoma. Aging (Albany NY) 12, 25865-25877. <https://doi.org/10.18632/aging.202151>
9. Kjaer, S. K., Dehlendorff, C., Belmonte, F. et al. (2021) Real-world effectiveness of human papillomavirus vaccination against cervical cancer. J. Natl. Cancer Inst. 113, 1329-1335. <https://doi.org/10.1093/jnci/djab080>
10. Larionova, I., Rakina, M., Ivanyuk, E. et al. (2022) Radiotherapy resistance: identifying universal biomarkers for various human cancers. J. Cancer Res. Clin. Oncol. 148, 1015-1031. <https://doi.org/10.1007/s00432-022-03923-4>
11. Li, J. H., Liu, S., Zhou, H. et al. (2014) starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 42(Database issue), D92-D97. <https://doi.org/10.1093/nar/gkt1248>
12. Liu, G. X., Tan, Y. Z., He, G. C. et al. (2021) EMX2OS plays a prognosis-associated enhancer RNA role in gastric cancer. Medicine (Baltimore) 100, e27535. <https://doi.org/10.1097/MD.0000000000027535>
13. Paraskevopoulou, M. D., Hatzigeorgiou, A. G. (2016) Analyzing miRNA-lncRNA interactions. Methods Mol. Biol. 1402, 271-286. <https://doi.org/10.1007/978-1-4939-3378-5_21>
14. Shelley, C. E., Barraclough, L. H., Nelder, C. L. et al. (2021) Adaptive radiotherapy in the management of cervical cancer: review of strategies and clinical implementation. Clin. Oncol. (R. Coll. Radiol.) 33, 579-590. <https://doi.org/10.1016/j.clon.2021.06.007>
15. Sherman, B. T., Hao, M., Qiu, J. et al. (2022) DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 50, W216-W221. <https://doi.org/10.1093/nar/gkac194>
16. Tong, C. C., Luk, M. Y., Chow, S. M. et al. (2002) Cervical nodal metastases from occult primary: undifferentiated carcinoma versus squamous cell carcinoma. Head Neck 24, 361-369. <https://doi.org/10.1002/hed.10054>
17. Tong, R., Zhang, J., Wang, C. et al. (2020a) Inhibition of miR-574-5p suppresses cell growth and metastasis and enhances chemosensitivity by targeting RNA binding protein QKI in cervical cancer cells. Naunyn Schmiedebergs Arch. Pharmacol. 393, 951-966. <https://doi.org/10.1007/s00210-019-01772-6>
18. Tong, R., Zhang, J., Wang, C. et al. (2020b) LncRNA PTCSC3 inhibits the proliferation, invasion and migration of cervical cancer cells via sponging miR-574-5p. Clin. Exp. Pharmacol. Physiol. 47, 439-448. <https://doi.org/10.1111/1440-1681.13186>
19. Tsikouras, P., Zervoudis, S., Manav, B. et al. (2016) Cervical cancer: screening, diagnosis and staging. J. BUON 21, 320-325.
20. Wang, P., Chow, S. C. (2021) Sample size re-estimation in clinical trials. Stat. Med. 40, 6133-6149. <https://doi.org/10.1002/sim.9175>
21. Wang, Z., Zhang, C., Chang, J. et al. (2020) LncRNA EMX2OS, regulated by TCF12, interacts with FUS to regulate the proliferation, migration and invasion of prostate cancer cells through the cGMP-PKG signaling pathway. Onco Targets Ther. 13, 7045-7056. <https://doi.org/10.2147/OTT.S243552>
22. Wu, B., Xi, S. (2021) Bioinformatics analysis of differentially expressed genes and pathways in the development of cervical cancer. BMC Cancer 21, 733. <https://doi.org/10.1186/s12885-021-08412-4>
23. Xia, W. T., Qiu, W. R., Yu, W. K. et al. (2023) Identifying TME signatures for cervical cancer prognosis based on GEO and TCGA databases. Heliyon 9, e15096. <https://doi.org/10.1016/j.heliyon.2023.e15096>
24. Yao, H., Jiang, X., Fu, H. et al. (2022) Exploration of the immune-related long noncoding RNA prognostic signature and inflammatory microenvironment for cervical cancer. Front. Pharmacol. 13, 870221. <https://doi.org/10.3389/fphar.2022.870221>
25. Zhang, H., Luo, Y. B., Wu, W. et al. (2021) The molecular feature of macrophages in tumour immune microenvironment of glioma patients. Comput. Struct. Biotechnol. J. 19, 4603-4618. <https://doi.org/10.1016/j.csbj.2021.08.019>
26. Zhang, H. M., Cui, M. Y., Chen, Z. H. (2023) EMX2OS targeting IGF2BP1 represses Wilms’ tumour stemness, epithelial-mesenchymal transition and metastasis. J. Genet. 102, 12. <https://doi.org/10.1007/s12041-022-01411-9>
27. Zhang, X., Xie, K., Zhou, H. et al. (2020) Role of non-coding RNAs and RNA modifiers in cancer therapy resistance. Mol. Cancer 19, 47. <https://doi.org/10.1186/s12943-020-01171-z>
28. Zheng, J., Cao, B., Zhang, X. et al. (2020) Immune-related four-lncRNA signature for patients with cervical cancer. Biomed Res. Int. 2020, 3641231. <https://doi.org/10.1155/2020/3641231>
front cover

ISSN 0015-5500 (Print) ISSN 2533-7602 (Online)

Open access journal

Submissions

Archive